Nashik: The city recorded a marginal rise in dengue cases between Jan 1 and 21, compared to the cases reported in Dec last year.

Climate change poses as a biggest environmental threat. It substantially affects pathogens (parasites, viruses and bacteria), ...

Pune, A man suspected to have contracted Guillain-Barré syndrome has died in Maharashtra's Solapur district, while the number of cases of the immunological nerve disorder in Pune rose to 110, health ...

Guillain-Barré Syndrome is a rare neurological disorder in which a person's immune system attacks the peripheral nervous ...

Tingling, weakness of hand-grip or foot drop could signal Guillain-Barré Syndrome (GBS), said <a target=_blank href=http ...

The study under PM-ABHIM assumes significance as India has limited data on zoonotic diseases such as Nipah infection, Ebola ...

Valneva’s growth potential lies in Ixchiq, but risks remain. Find out why VALN stock is still a Buy with a good long-term ...

Valneva’s vaccine was highly immunogenic in both dose groups. A full dose of the vaccine exhibited a more robust immune response compared to a half dose by providing protective antibody titers already ...

Valneva (VALN) announced results for its Phase 2 clinical trial evaluating the safety and immunogenicity of two different dose levels of its ...

Valneva chikungunya vaccine shows strong, sustained immune response in adolescents, supporting potential approvals in Brazil and other regions.

The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.

Valneva has announced positive outcomes from its Phase III VLA1553-321 trial of the single-shot IXCHIQ chikungunya virus ...